A successful biotechnology manager must know what to expect during the early stages of a startup and be eager to fight to overcome obstacles. Our experience tells us, for example, that candidates ...
Hosted on MSN1y
Puma Biotechnology begins Phase II trial of lung cancer drugUS-based biopharmaceutical company Puma Biotechnology has initiated a Phase II clinical trial to evaluate alisertib, a monotherapy designed to treat extensive-stage small-cell lung cancer (SCLC).
with hints of efficacy and a boatload more patients in phase 1 waiting for more evaluation. On balance, at these price levels, VIR stock is attractive, though risky. Vir Biotechnology (NASDAQ ...
Phase 2 pivotal trials to evaluate efficacy of THIO in combination with BeiGene’s checkpoint inhibitor (CPI) tislelizumab MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback